M1 Kliniken AG investor news & press releases

| Corporate News

In recent years, M1 Kliniken AG (ISIN: DE000A0STSQ8) has become the leading specialist for plastic and aesthetic beauty medicine in Germany.

| Corporate News

M1 Kliniken AG (ISIN: DE000A0STSQ8) continued its growth course in the first half of 2019. In the first six months of the year, Germany’s market leader in the field of beauty medicine increased sales by 14% from EUR 28.9 million to EUR 32.9 million.

| Corporate News

Today the Annual General Meeting 2019 of M1 Kliniken AG (ISIN: DE000A0STSQ8) took place in Berlin. The attendance was 77 %. The shareholders approved the proposal of the Management Board and Supervisory Board to distribute a dividend of 0.30 Euro per share for the financial year 2018.

| Corporate News

After M1 Kliniken AG was able to increase the number of specialist centres to 24 by the end of the year in 2018, the group has created the prerequisites for further growth in Germany and abroad. The expansion of room capacities created the basis for a significantly larger number of doctors in aesthetic medicine.

| Corporate News

M1 Kliniken AG today published its consolidated financial statements for 2018. The M1 Group further expanded its market leadership in Germany in the field of beauty medicine and expanded its range of services with “M1 Laser” and “M1 Dental” to include dermatological laser and aesthetic dental treatments.

| Corporate News

M1 Kliniken AG has continued its profitable growth in 2018 and invested considerably in further expansion. In the 2018 financial year, the M1 Group increased sales by a good 38% year-on-year to EUR 65.2 million (preliminary figures). Despite the start-up costs of the numerous new locations profit increased in 2018.

| Corporate News

M1 Kliniken AG (ISIN: DE000A0STSQ8) is driving growth in the field of medical cosmetic products. Under its own brand M1 SELECT, the beauty medicine specialist has been offering a selected range of high-quality active cosmetics with a focus on skin and facial care since December 2017.

| Corporate News

M1 Kliniken AG (ISIN: DE000A0STSQ8) has continued its profitable growth course in 2018 and invested considerably in further growth. As the leading private German provider of health services in the field of beauty medicine, the group of companies benefits from the increasing demand for plastic and aesthetic treatments

| Corporate News

M1 Kliniken AG (ISIN: DE000A0STSQ8) has expanded its range of services to include aesthetic laser treatments. They are already offered under the new brand “M1 Laser” at nine locations in Germany. The existing premises of “M1 Med Beauty” are used for this purpose.

| Corporate News

M1 Kliniken AG (ISIN: DE000A0STSQ8), market leader in the field of beauty medicine in Germany, has opened the first “M1 Med Beauty” specialist centre outside its home market in Vienna. In the Austrian capital, M1’s experienced specialists are now available for all aspects of aesthetic medicine.

| Corporate News

M1 Kliniken AG continues its expansion course in 2018. 4 new specialist centres have been opened so far this year. Two more are to follow by the end of the year. The M1 Group will thus operate a total of 24 specialist centres for aesthetic treatments by the end of 2018.

| Corporate News

The Management Board of M1 Kliniken AG today decided to increase the company’s share capital by up to 10% against cash contributions on the basis of the authorization granted by the Annual General Meeting by partially utilizing the authorized capital 2018. The Supervisory Board has approved the decision.